pilocarpine has been researched along with Facial Hemiatrophy in 1 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
Facial Hemiatrophy: A syndrome characterized by slowly progressive unilateral atrophy of facial subcutaneous fat, muscle tissue, skin, cartilage, and bone. The condition typically progresses over a period of 2-10 years and then stabilizes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Congenital nonprogressive facial hemiatrophy is reported in association with anisometropia and ipsilateral cornea, iris, angle abnormalities, and juvenile glaucoma." | 1.26 | Congenital nonprogressive facial hemiatrophy with ipsilateral eye abnormalities and juvenile glaucoma. ( Cohen, JS, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, JS | 1 |
1 other study available for pilocarpine and Facial Hemiatrophy
| Article | Year |
|---|---|
Congenital nonprogressive facial hemiatrophy with ipsilateral eye abnormalities and juvenile glaucoma.
Topics: Animals; Child; Diabetes Mellitus, Type 1; Eye Abnormalities; Facial Hemiatrophy; Female; Glaucoma; | 1979 |